Primary faculty

Research interests: Cancer cell heterogeneity and plasticity; cancer stem cells; stem cells; epigenetics; noncoding RNAs; prostate cancer

Research interests: Deubiquitinating and chromatin-modifying enzymes in cancer development and progression.

Atanassov Lab

Research interests: Microenvironmental regulation of extracellular matrix proteins promoting cancer progression and tissue healing aspects of regenerative medicine

Chakraborty Lab

Research interests: Mitochondrial unfolded protein response and cancer health disparities

Chandra Lab

Research interests: Exploiting crosstalk between estrogen receptors and p53 (wild type and mutant) signaling for developing novel therapeutic strategies against cancer

Das Lab

Research interests: Dissect epigenetic mechanisms that regulate physiological and pathological processes and translate them into therapeutics

Research interests: Gene regulation, GPCR signaling, and therapeutic development in pancreatic cancer

Feigin Lab

Research interests: Preclinical testing of novel therapeutics using in vivo model systems with a focus in prostate and bladder cancer

Research interests: Understanding how tumor suppressor gene regulated molecular pathways influence cancer progression and therapeutic resistance

Goodrich Lab

Research interests: Anticancer drug discovery, development and mechanism of action (MOA) studies; IND-enabling studies

Research Interests: small RNAs, RNA binding proteins, RNA therapeutics, circulating RNAs, metastasis

Research interests: MDM2, MDM4, Small molecule inhibitor, Cell death, Cell cycle

Research interests: Genetic and epigenetic drivers of urological malignancies

Research faculty - Assistant Professors of Oncology

Research interests: Prostate cancer biology, Mitochondrial UPR and Metabolism, Drug Target Discovery, lncRNA, Genomic Instability

Research interests:  To understand and prevent prostate cancer castration resistance

Research interests: Establishment, characterization, and utilization of pre-clinical in vivo models for basic and translational cancer research

Joint appointment

Research interests: Therapeutically targeting prostate cancer and BPH stem cells ABC transporter regulation of stem cell properties Role of cancer stem cells in tumor heterogeneity

Research interests: Develop preclinical bladder cancer models (genetic engineered mouse models and patient-derived organoids), identify biomarkers associated with treatment responses, and improve chemotherapy efficacy by inhibiting the nucleotide excision repair pathway

Research Interests: DNA damage repair, tumor microenvironment signaling, and antiestrogen therapy in ovarian cancer

McLean Lab

Research interests: Multi-omics analysis and integration to better understand dysregulated tumor, microenvironment and immune metabolism

Rosario Lab

Research interests: Vascular biology of head and neck cancers Chemoprevention of oral cancer Multimodal imaging (CT, US, Photoacoustic imaging)

Research interests: Mechanism of differentiation responses and resistance to FLT3 targeted therapy in AML

Emeritus faculty

Adjunct faculty

Daniel Gewirth, PhD
Daniel Gewirth, PhD
Principal Research Scientist
Hauptman-Woodward Medical Research Institute
David Heppner, PhD
David Heppner, PhD
Assistant Professor of Medicinal Chemistry
University at Buffalo
Dr. Jonathan Lovell, University at Buffalo
Jonathan Lovell, PhD
Associate Professor
University at Buffalo
Gene Morse, PharmD, FCCP, BCPS
Gene Morse, PharmD, FCCP, BCPS
Director, Translational Pharmacology Research Core
University at Buffalo
Dr. Robert M. Straubinger
Robert Straubinger, PhD
Distinguished Professor of Pharmaceutical Sciences
University at Buffalo
Yuesheng Zhang, MD, PhD
Yuesheng Zhang MD, PhD
Professor
VCU Massey Cancer Center